Physician profile
Dana L Trippi
NPI 1124021175
$305,284.02
in general payments reported to CMS, 2019-2025
8 companies · $137K in 2025
The $137K reported for 2025 was more than what 99% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.70 · 2020: $78.38 · 2021: $252 · 2022: $22K · 2023: $28K · 2024: $119K · 2025: $137K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $237K · Travel and Lodging: $36K · Food and Beverage: $6,945 · Consulting Fee: $2,180 · Education: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $237,279.54 |
| Travel and Lodging | $36,025.71 |
| Food and Beverage | $6,945.24 |
| Consulting Fee | $2,180.00 |
| Education | $526.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $173,652.43 | 2019-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $131,521.35 | 2024-2025 | Zepbound, Taltz, Jardiance |
| Currax Pharmaceuticals LLC | $29.51 | 2022 | |
| Echosens North America, INC. | $25.96 | 2025 | Fibroscan |
| Rhythm Pharmaceuticals, INC. | $22.54 | 2023 | Imcivree |
| Boston Scientific Corporation | $18.53 | 2025 | General - Pain Management |
| Supernus Pharmaceuticals, INC. | $13.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Trippi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.